10x Genomics Inc is a life science technology company based in the United States. ... The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, ...

PLEASANTON, Calif., Oct. 15, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of two new Chromium products intended ...

Advancing Large-Scale Single Cell Research. Building on a record year of Chromium product releases in 2024, 10x Genomics announced plans to enable high-performance, mega-scale single cell analysis ...

10x Genomics Inc is a life science technology company based in the United States. ... The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, ...

10x Genomics specializes in developing products that enhance our understanding of biological systems. Its offerings range from instruments like the Chromium Controller to consumables and ...

10x Genomics stock crashed Thursday after the medtech reported preliminary third-quarter sales that widely missed Street expectations. ... Chromium, 10x's oldest system, brought in $7.6 million.

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at where 10x Genomics, Inc. (NASDAQ:TXG) stands against the other genomics ...

Given that 10x Genomics kits are mainly used with Illumina NGS systems due to their widespread use, an analyst predicts that Chromium (10x’s single-cell business) revenue will decrease by 10%.

For the quarter ended March 2025, 10x Genomics (TXG) reported revenue of $154.88 million, up 9.8% over the same period last year. EPS came in at -$0.36, compared to -$0.50 in the year-ago quarter ...

10x Genomics Unveils Innovation ... Building on a record year of Chromium product releases in 2024, 10x Genomics announced plans ... giving researchers full control and flexibility over how ...